22nd Century Group, Inc. engages in the development of technology. The firm’s technology helps in increasing or decreasing the level of nicotine and nicotinic alkaloids in tobacco plants and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. Its products include X-22, modified risk cigarettes, spectrum government research cigarettes, magic 0 and magic 2, moonlight, red sun, variable nicotine-level research cigarettes and verfola. The company was founded on September 12, 2005 and is headquartered in Williamsville, NY. The listed name for XXII is 22nd Century Group, Inc. Common Stock.